Recursion Pharmaceuticals (RXRX)

Common Shares
Sell: $3.62|Buy: $3.66|Change: 0.10 (-2.65%)

Company profile

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Address





Sector 

Healthcare


Previous key dates

NameKey Date
KeyBanc 2026 Healthcare Forum2026-03-17T00:00:00
Jefferies 2026 Biotech on the Beach Summit2026-03-11T00:00:00
Leerink Partners 2026 Global Healthcare Conference2026-03-09T00:00:00
TD Cowen 46th Annual Healthcare Conference2026-03-02T00:00:00
Recursion Pharmaceuticals Inc Annual Report for 20252026-02-27T00:00:00
Recursion Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252026-02-25T08:00:00
Recursion Pharmaceuticals Inc Fourth Quarter Earnings Results for 20252026-02-25T00:00:00
44th Annual J.P. Morgan Healthcare Conference2026-01-16T10:30:00
Jefferies Global Healthcare Conference2025-11-18T10:30:00
Guggenheim 2nd Annual Healthcare Innovation Conference2025-11-11T08:00:00
Recursion Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-11-05T08:00:00
Recursion Pharmaceuticals Inc Third Quarter Earnings Result for 20252025-11-05T00:00:00
Recursion Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20252025-08-05T08:00:00
Recursion Pharmaceuticals Inc Second Quarter Earnings Results for 20252025-08-05T00:00:00
Recursion Pharmaceuticals Inc Annual General Meeting for 20252025-06-18T12:00:00
J.P. Morgan 53rd Annual Global Technology, Media and Communications Conference2025-05-15T00:00:00
BofA Securities 2025 Health Care Conference2025-05-13T10:00:00
Recursion Pharmaceuticals Inc First Quarter Earnings Conference Call for 20252025-05-05T08:00:00
Recursion Pharmaceuticals Inc First Quarter Earnings Result for 20252025-05-05T00:00:00
Needham 24th Annual Virtual Healthcare Conference2025-04-07T08:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.